Stocksigma LogoStocksigma Logo

Lord's Mark Industries Releases H1 Investor Presentation Outlining Growth Strategy and Targets

Lord's Mark Industries outlined its strategic roadmap and financial projections across MedTech, diagnostics, and renewable energy

Lord's Mark Industries Releases H1 Investor Presentation Outlining Growth Strategy and Targets

Lords Mark Industries Ltd · Investor Presentation · 18 Nov 2026, 1:08 am

Lord's Mark Industries Releases H1 Investor Presentation Outlining Growth Strategy and Targets Lord's Mark Industries outlined its strategic roadmap and financial projections across MedTech, diagnostics, and renewable energy. The company forecasts revenue to expand 3.6x from ₹710 Cr in FY25 to ₹2,586 Cr by FY29, driven by high-margin IVD, MedTech, and dialysis segments. Over the same timeframe, EBITDA is expected to grow 8.7x to ₹650.36 Cr (margin reaching 25.1%), with adjusted PAT climbing to ₹422 Cr. The company holds a secured order book of ~₹2,000 Cr in renewable energy and plans a ₹500 Cr FPO or preferential allotment in FY27.

Original exchange filing (PDF)

More announcements from Lords Mark Industries Ltd

All Lords Mark Industries Ltd announcements